Source: REUTERS, 1/29/18

Bayer’s (BAYGn.DE) quest to win regulatory approval for its planned takeover of Monsanto (MON.N) ran into further delays on Monday as European Union antitrust investigators extended their investigation by five working days until March 12. The ongoing proceedings would have given the German drugs and pesticides maker until midnight on Monday to offer further concessions to EU regulators - or request another extension of up to 10 working days. 

For more of this story, click here.